- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,289,327
- Total 13F shares
- 3,076,255
- Share change
- -160,094
- Total reported value
- $31,040,000
- Price per share
- $10.09
- Number of holders
- 12
- Value change
- -$1,629,988
- Number of buys
- 4
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4.1%
|
1,200,000
|
$12,624,000 | — | 31 Dec 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.4%
|
700,000
|
$7,364,000 | — | 31 Dec 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
300,000
|
$3,156,000 | — | 31 Dec 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
1%
|
300,000
|
$3,156,000 | — | 31 Dec 2017 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.86%
|
252,348
|
$2,655,000 | — | 31 Dec 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.68%
|
200,000
|
$2,104,000 | — | 31 Dec 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.51%
|
150,000
|
$1,578,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.25%
|
74,100
|
$779,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
25,268
|
$266,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
22,036
|
$232,000 | — | 31 Dec 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
10,800
|
$114,000 | — | 31 Dec 2017 | |
| KBC Group NV |
13F
|
Company |
0%
|
1,000
|
$11,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
797
|
$8,000 | — | 31 Dec 2017 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2018
As of 31 Mar 2018,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,076,255 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
13
Q1 2018 holders
12
Holder diff
-1
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.